findmyKOL
Clinical trialNCT02561273CompletedPhase 1/PHASE2Interventional

Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma

SponsorUniversity of NebraskaEnrollment54Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveHepatosplenic T-Cell LymphomaPeripheral T-Cell Lymphoma, Not Otherwise SpecifiedStage II Angioimmunoblastic T-cell LymphomaStage II Enteropathy-Associated T-Cell Lymphoma+4 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • City of Hope Comprehensive Cancer Center

    Duarte, California, United States

  • Stanford Cancer Institute

    Palo Alto, California, United States

  • University of Colorado Cancer Center, Anschutz Cancer Pavilion

    Aurora, Colorado, United States

  • Emory University/winship Cancer Institute

    Atlanta, Georgia, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Washington University School of Medicine

    St Louis, Missouri, United States

  • University of Nebraska Medical Center

    Omaha, Nebraska, United States

  • Memorial Sloan-Kettering Cancer Center

    New York, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Sept 2015
Primary completion
1 Nov 2019
Completion
1 Nov 2020
Last update posted
13 Dec 2023
Registered enrollment
54
Registry id
NCT02561273
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.